medline.ch Onkologie Haut

	Dissecting the MAPK signaling landscape in malignant melanoma: from BRAF and NRAS mutations to precision combination therapies. Front Cell Dev Biol Fang X, Wang S, Fu S. PMID: 41613941 [PubMed]
	Clinical Molecular Pathology and Treatment Developments in Advanced Uveal Melanoma: State of the Art. Oncol Res Dore S, Sacchi M, Pinna A, Palmieri G, Paliogiannis P. PMID: 41613812 [PubMed - indexed for MEDLINE]
	The Frontier of Melanoma Treatment: Defeating Immunotherapy Resistance-A Systematic Review. Oncol Res Mozga K, Synowiecka O, Rydzyk I, Marek A, Wieczorek E, Petniak A, Gil-Kulik P. PMID: 41613791 [PubMed - indexed for MEDLINE]
	Integrating cuproptosis- and ferroptosis-related gene signatures to predict prognosis, immunotherapy response, and drug sensitivity in patients with skin cutaneous melanoma. Front Immunol Dong H, Huang Y, Shen J, Ding Z, Wang W, Li Y. PMID: 41613147 [PubMed - indexed for MEDLINE]
	Stereotactic body radiation therapy for oligometastatic melanoma: a real-world study of the ESTRO/EORTC nomenclature. Radiat Oncol Heurlin E, Grozman V, Egyhazi Brage S, Lindberg K, Helgadottir H. PMID: 41612458 [PubMed - as supplied by publisher]
	Exogenous Hormone Use and Breslow Thickness in Women With Cutaneous Melanoma: A Retrospective Cohort Study. Int J Dermatol Niforou A, Lagiou P, Geller AC, Dessypris N, Stratigos AJ. PMID: 41612167 [PubMed - as supplied by publisher]
	Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial. Nat Cancer Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson WE 3rd, Wada DA, Plaza JA, In GK, Ikeguchi A, Hyngstrom J, Brohl AS, Chmielowski B, Khushalani NI, Markowitz J, Monroe M, Contreras CM, Bowles T, Norman K, Medina E, Gonzalez CR, Baselga-Carretero I, Garcilazo IP, Vega-Crespo A, Chen JM, Deen NNA, Patel SP, Grossmann KF, Sondak VK, Sharon E, Moon J, Wu MC, Ribas A. PMID: 41611998 [PubMed - as supplied by publisher]
	Partial-EMT in oral squamous cell carcinoma: molecular circuitry and clinical translation. Int J Oral Sci Wang C, Sarubo M, Chen S, Kudo Y. PMID: 41611665 [PubMed - indexed for MEDLINE]
	Prospective Study to Assess the Utility and Validity of a Chromameter in the Assessment ofÂ Infantile Hemangiomas. Pediatr Dermatol Sánchez-Espino LF, Bahrani B, Pennal A, Pope E. PMID: 41611263 [PubMed - indexed for MEDLINE]
	A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol. PLoS One Selvaraj KJ, Damian DL, Lyons JG, Wilmott JS, Ferguson PM, McGrady M, Bartula I, Lo SN, Scolyer RA, Ferguson AL, Saw RPM. PMID: 41610103 [PubMed - indexed for MEDLINE]
	Knowledge Gaps on Skin Cancer and Sun Protection in Organ Transplant Recipients Under Long-term Immunosuppression. Acta Derm Venereol Wiedenmayer N, Rocholl M, Enk AH, Lonsdorf AS. PMID: 41609787 [PubMed - indexed for MEDLINE]
	Journal Club: Mastocytosis: across the spectrum: pathobiology, clinical evaluation, and evolving therapies. Eur J Dermatol Briones LJ, Sánchez BR, González JM, Díaz LZ, Alonso MP, Goller S, Ferreira CS, Piqueras PG. PMID: 41608943 [PubMed - indexed for MEDLINE]
	Long-lasting effects of the COVID-19 pandemic on the incidence and depth of malignant melanoma. Eur J Dermatol Possanner C, Spurny-Dworak J, Breier F, Stella A, Feldmann R, Steiner A, Posch C. PMID: 41608918 [PubMed - indexed for MEDLINE]
	Immune landscape of melanoma: Tumor microenvironment, resistance mechanisms, and predictive biomarkers. World J Clin Oncol Oliveira MMGL, Lemos CS, Brazão MLS, Rodrigues ALA, do Nascimento EDC, Cardoso EMP, Arantes MFF, de Melo FF. PMID: 41608340 [PubMed]
	Canonical and noncanonical NF-ÎºB signaling in uveal melanoma: mechanisms, microenvironment, and therapeutic modulation. Med Hypothesis Discov Innov Ophthalmol Jalali S, Dianat I, Baghi Keshtan S, Izadfar R, Esfandiari HR, Lohrasbi G, Firuzpour F. PMID: 41608133 [PubMed]
	Circulating tumor DNA accelerates diagnosis and treatment guidance for metastatic uveal melanoma with hepatic lesions not amenable to biopsy. Melanoma Res Kissinger CR, Miller DJ, Li Z, Ashraf UM, Hubbard G, Wilson MA. PMID: 41607212 [PubMed - as supplied by publisher]
	Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trials. Melanoma Res Duarte-Bateman D, Escandón JM, Shen A, Chen Y, Ko J, Melenhorst JJ, Tufaro A, Kennedy LB, Isaacs J, Gastman BR. PMID: 41607207 [PubMed - as supplied by publisher]
	Comment on 'Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden'. Br J Dermatol Qi J, Nie G. PMID: 41606788 [PubMed - as supplied by publisher]
	The Immuno-Metabolic Crosstalk in Lung Squamous Cell Carcinoma: Prognostic Insights and Therapeutic Clues. Chem Biol Drug Des Xue H, Li H, Han S, Zhang X, Liu T, Bu P, Liang H. PMID: 41606426 [PubMed - indexed for MEDLINE]
	Incidence, risk factors, and outcomes of ovarian metastasis in early-stage cervical cancer: a population-based analysis of 983 patients. Arch Gynecol Obstet Gennari P, Luft D, Mészáros J, Ignatov A. PMID: 41606252 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 141146

Seite 1 von 7058

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung